Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #204230 on Biotech Values
puravida
09/12/16 8:23 AM
#204231 RE: puravida #204230
Titan V
09/12/16 9:40 PM
#204255 RE: puravida #204230
DewDiligence
12/08/16 10:31 AM
#206778 RE: puravida #204230
05/08/17 3:19 PM
#211142 RE: puravida #204230
[River Vision’s] development-stage medicine, teprotumumab (RV001) [is] a fully human monoclonal antibody (mAb) currently in development for Thyroid Eye Disease (TED), a rare, autoimmune inflammatory disorder.